Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

-0.23 (-2.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.71B
Current PE16.08
Forward PE 12.06
2yr Forward PE 10.61
See more stats
Estimates Current Quarter
Revenue$87.94 Million
Adjusted EPS$0.22
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Ironwood Pharmaceuticals, Inc. Stock, NASDAQ:IRWD

100 Summer Street, Suite 2300, Boston, Massachusetts 02110
United States of America
Phone: +1.617.621.7722
Number of Employees: 232


Ironwood Pharmaceuticals, Inc. is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Its products include linaclotide, a guanylate cyclase type-C agonists which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller on January 5, 1998 and is headquartered in Boston, MA.